Stockreport

Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF Current cash expected to fund activities into 2026 BOTHELL, Wash., March 28, 2024 BUSINESS WIRE Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on deve [Read more]